학술논문

Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors
Document Type
Journal
Source
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY; JAN 16 2024, 11 p1324898 9p.
Subject
Language
English
ISSN
2296634X